Literature DB >> 26647176

Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy.

Merih Oray1, Pinar Cakar Ozdal2, Zafer Cebeci1, Nur Kir1, Ilknur Tugal-Tutkun1.   

Abstract

PURPOSE: To describe fulminant toxoplasma retinochoroiditis induced by corticosteroid monotherapy.
METHODS: Clinical records of nine patients were reviewed.
RESULTS: All patients (five female, four male; aged 15-64 years) had been misdiagnosed as unilateral non-infectious uveitis and given systemic and/or local corticosteroid injections elsewhere. Mean disease duration before referral was 105.6 ± 71 (45-240) days. Visual acuity at presentation was <20/200 in six eyes. Average lesion size was 6.6 disc areas in eight eyes and all four quadrants were involved in one. Toxoplasma DNA was detected in eight tested eyes. Mean duration of anti-toxoplasmic therapy was 92.5 ± 37.1 days. Three eyes developed rhegmatogenous retinal detachment. Four patients underwent pars plana vitrectomy. Final visual acuity was <20/200 in five eyes.
CONCLUSIONS: Iatrogenic immunosuppression due to initial misdiagnosis may lead to an aggressive course and serious complications of ocular toxoplasmosis, a potentially self-limiting infection.

Entities:  

Keywords:  Anti-toxoplasmic therapy; corticosteroid; necrotizing retinitis; ocular toxoplasmosis; retinochoroiditis

Mesh:

Substances:

Year:  2015        PMID: 26647176     DOI: 10.3109/09273948.2015.1057599

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  5 in total

1.  The Role of Corticosteroids in Treating Acute Ocular Toxoplasmosis in an Immunocompetent Patient: A Case Report.

Authors:  Hung-Yi Lin; Wan-Ju Annabelle Lee
Journal:  Front Med (Lausanne)       Date:  2022-06-29

Review 2.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

3.  Measurement of the active toxoplasma retinochoroiditis lesion size during the disease course with swept-source optical coherence tomography angiography: A retrospective image analysis.

Authors:  Ferdane Atas; Mahmut Kaya; Tugce Toprak; Betul Akbulut Yagci; Alper Selver; Ali Osman Saatci
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

4.  A novel dense granule protein, GRA41, regulates timing of egress and calcium sensitivity in Toxoplasma gondii.

Authors:  Kaice A LaFavers; Karla M Márquez-Nogueras; Isabelle Coppens; Silvia N J Moreno; Gustavo Arrizabalaga
Journal:  Cell Microbiol       Date:  2017-05-17       Impact factor: 3.715

5.  Intravitreal dexamethasone implant as an option for anti-inflammatory therapy of tuberculosis uveitis.

Authors:  Murat Hasanreisoglu; Gokcen Gulpinar Ikiz; Zeynep Aktas; Sengul Ozdek
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.